Roxana Mehran, M.d.

Biography

 Professor of Medicine (Cardiology) and Health Evidence and Policy and Director of Interventional Cardiovascular Research and Clinical Trials at Mount Sinai School of Medicine, New York, NY. She completed her training in Internal Medicine at University of Connecticut and served as chief medical resident before completing cardiology and interventional cardiology fellowships at Mount Sinai Medical Center. Dr. Mehran is internationally recognized for her work in multicenter, multinational clinical trials, specializing in complex data analysis. She has developed several risk scores for bleeding and acute kidney injury. Previously (2004-2010), Dr. Mehran was Associate Professor of Medicine and Director of Outcomes Research, Data Coordinating and Analysis at the Center of Interventional Vascular Therapies at Columbia University. She is reknowned for her vast experience working with regulatory agencies to design and conduct clinical trials. She is currently one of several lead investigators who collaborate with the FDA to develop standard definitions for clinical trials in cardiovascular disease. She is Chief Scientific Officer at the Cardiovascular Research Foundation for the past 12 years, Co-director of the Transcatheter Cardiovascular Therapeutics (TCT) meeting for the past 15 years, and an editorial board member of multiple cardiovascular journals. She has served on the board of trustees of the Society of Cardiac Angiography and Interventions (SCAI), program committee of the American Heart Association, writing committee of the ACC/AHA PCI guidelines. She is currently on the board of directors for Harboring Hearts and program chair for SCAI- Women in Innovation (WIN) Initiative.

Research Interest

 Internal Medicine